{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T04:06:50Z","timestamp":1790309210573,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T00:00:00Z","timestamp":1740614400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003852","name":"Campania Region","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003852","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.diabres.2025.112076","type":"journal-article","created":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T18:19:21Z","timestamp":1740853161000},"page":"112076","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Characterisation of transfusion-dependent prediabetes using continuous glucose monitoring: The Haemoglycare study"],"prefix":"10.1016","volume":"222","author":[{"given":"Angela","family":"Zanfardino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulsum","family":"Ozen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Ippolito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Roberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silverio","family":"Perrotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Iafusco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele Miraglia","family":"del Giudice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maddalena","family":"Casale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.diabres.2025.112076_b0005","first-page":"1826","volume":"11","author":"Casale","year":"2022","journal-title":"J ClinMed"},{"issue":"4","key":"10.1016\/j.diabres.2025.112076_b0010","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1586\/17474086.2016.1136209","article-title":"Diabetes and glucose metabolism in thalassemia major: an update","volume":"9","author":"De Sanctis","year":"2016","journal-title":"Expert RevHematol"},{"issue":"4","key":"10.1016\/j.diabres.2025.112076_b0015","doi-asserted-by":"crossref","first-page":"332","DOI":"10.2174\/1573399811309040005","article-title":"Iron overload and glucose metabolism in subjects with \u03b2-thalassaemia major: an overview","volume":"9","author":"De Sanctis","year":"2013","journal-title":"Curr Diabetes Rev"},{"issue":"2","key":"10.1016\/j.diabres.2025.112076_b0020","first-page":"46","article-title":"Risk factors for endocrine complications in transfusion-dependentthalassemiapatients on chelation therapy with deferasirox: a risk assessment study from a multi-center nation-wide cohort","volume":"107","author":"Casale","year":"2022","journal-title":"Haematologica"},{"issue":"12","key":"10.1016\/j.diabres.2025.112076_b0025","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1002\/ajh.23844","article-title":"Endocrine function and bone diseaseduring long-termchelation therapy with deferasirox in patients with \u03b2-thalassemia major","volume":"89","author":"Casale","year":"2014","journal-title":"Am J Hematol"},{"issue":"4","key":"10.1016\/j.diabres.2025.112076_b0030","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/bjh.12557","article-title":"Cardiac complications and diabetes in thalassaemia major: a large historical multicentre study","volume":"163","author":"Pepe","year":"2013","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.diabres.2025.112076_b0035","first-page":"344","article-title":"Red cell transfusion decreases hemoglobin A1c in patients with diabetes","volume":"57","author":"Spencer","year":"2011","journal-title":"ClinChem"},{"issue":"8","key":"10.1016\/j.diabres.2025.112076_b0040","first-page":"1245","article-title":"Hemoglobin variants and hemoglobin A1c analysis: problem solved?","volume":"49","author":"Sacks","year":"2003","journal-title":"ClinChem"},{"key":"10.1016\/j.diabres.2025.112076_b0045","unstructured":"Performance Metrics for Continuous Glucose Interstitial Glucose Monitoring (POCT05-A); Clinical and Laboratory Standards Institute (2020) https:\/\/clsi.org\/media\/tqkJ5mmn\/poct05ed2_sample.pdf."},{"key":"10.1016\/j.diabres.2025.112076_b0050","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.diabres.2018.05.026","article-title":"Continuous glucose monitoring is more sensitive than HbA1c and fasting glucose in detecting dysglycaemia in a Spanish population without diabetes","volume":"142","author":"Rodriguez-Segade","year":"2018","journal-title":"Diabetes Res Clin Pract"},{"issue":"3","key":"10.1016\/j.diabres.2025.112076_b0055","doi-asserted-by":"crossref","first-page":"490","DOI":"10.4103\/2230-8210.111647","article-title":"Detection of glycemic abnormalities in adolescents with beta thalassemia using continuous glucose monitoring and oral glucose tolerance in adolescents and young adults with \u03b2-thalassemia major: pilot study","volume":"17","author":"Soliman","year":"2013","journal-title":"Indian J EndocrinolMetab"},{"issue":"1","key":"10.1016\/j.diabres.2025.112076_b0060","first-page":"65","article-title":"Evaluation of continuous glucose monitoring system for detection of alterations in glucose homeostasis in pediatric patients with \u03b2-thalassemia major","volume":"20","author":"El-Samahy","year":"2019","journal-title":"PediatrDiabetes"},{"key":"10.1016\/j.diabres.2025.112076_b0065","doi-asserted-by":"crossref","unstructured":"American Diabetes Association. Improving Care and Promoting Health in Populations: Standards of Medical Care in Diabetes-2020. Diabetes Care. 2020 43(Suppl 1):S7-S13. doi: 10.2337\/dc20-S001.","DOI":"10.2337\/dc20-S001"},{"issue":"Suppl 1","key":"10.1016\/j.diabres.2025.112076_b0070","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.2337\/dc23-S006","article-title":"Glycemic targets: standards of care in diabetes-2023","volume":"46","author":"ElSayed","year":"2023","journal-title":"Diabetes Care"},{"issue":"10","key":"10.1016\/j.diabres.2025.112076_b0075","doi-asserted-by":"crossref","first-page":"4356","DOI":"10.1210\/jc.2018-02763","article-title":"Continuous glucose monitoring profiles in healthy nondiabetic participants: a multicenter prospective study","volume":"104","author":"Shah","year":"2019","journal-title":"J ClinEndocrinolMetab"},{"issue":"3","key":"10.1016\/j.diabres.2025.112076_b0080","first-page":"198","article-title":"The real-life management of glucose homeostasis abnormalities in pediatric onco-hematological diseases: data from a national survey","volume":"41","author":"Zanfardino","year":"2024","journal-title":"PediatrHematol Oncol"},{"issue":"S3","key":"10.1016\/j.diabres.2025.112076_b0085","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1089\/dia.2023.0136","article-title":"What role might there be for continuous glucose monitoring in the assessment of diabetes risk?","volume":"25","author":"Miller","year":"2023","journal-title":"Diabetes Technol Ther"},{"issue":"2","key":"10.1016\/j.diabres.2025.112076_b0090","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1177\/19322968231197205","article-title":"Objective determination of eating occasion timing: combining self-report, wrist motion, and continuous glucose monitoring to detect eating occasions in adults with prediabetes and obesity","volume":"18","author":"Popp","year":"2024","journal-title":"J Diabetes Sci Technol"},{"issue":"12","key":"10.1016\/j.diabres.2025.112076_b0095","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/j.arcped.2009.09.007","article-title":"Holter glyc\u00e9mique et d\u00e9pistage du diab\u00e8te chez l'enfant atteint de mucoviscidose Value of continuous glucose monitoring in screening for diabetes in cystic fibrosis]","volume":"16","author":"Khammar","year":"2009","journal-title":"Arch Pediatr."},{"issue":"4","key":"10.1016\/j.diabres.2025.112076_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2024.108703","article-title":"Early glucose abnormalities revealed by continuous glucose monitoring associate with lung function decline in cystic fibrosis: a five-year prospective study","volume":"38","author":"Rakotoarisoa","year":"2024","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.diabres.2025.112076_b0105","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.diabres.2016.07.027","article-title":"Continuous glucose monitoring and HbA1c in the evaluation of glucose metabolism in children at high risk for type 1 diabetes mellitus","volume":"120","author":"Helminen","year":"2016","journal-title":"Diabetes Res Clin Pract"},{"issue":"2","key":"10.1016\/j.diabres.2025.112076_b0110","doi-asserted-by":"crossref","first-page":"e3777","DOI":"10.1002\/dmrr.3777","article-title":"Clinical care advice for monitoring of islet autoantibody positive individuals with presymptomatic type 1 diabetes","volume":"40","author":"Hendriks","year":"2024","journal-title":"Diabetes Metab Res Rev"},{"issue":"Suppl 22","key":"10.1016\/j.diabres.2025.112076_b0115","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/pedi.12392","article-title":"Dysregulation of glucose metabolism in preclinical type 1 diabetes","volume":"17","author":"Veijola","year":"2016","journal-title":"Pediatr Diabetes"},{"issue":"4","key":"10.1016\/j.diabres.2025.112076_b0120","doi-asserted-by":"crossref","first-page":"441.e1","DOI":"10.1016\/j.ajog.2023.04.021","article-title":"Continuous glucose monitoring in individuals undergoing gestational diabetes screening","volume":"229","author":"Fishel Bartal","year":"2023","journal-title":"Am J Obstet Gynecol"},{"issue":"8","key":"10.1016\/j.diabres.2025.112076_b0125","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.2337\/dci24-0036","article-title":"Continuous glucose monitoring in pregnancy: new insights into gestational diabetes with more to learn","volume":"47","author":"Scifres","year":"2024","journal-title":"Diabetes Care"},{"issue":"24","key":"10.1016\/j.diabres.2025.112076_b0130","first-page":"00439","article-title":"Continuous glucose monitoring (CGM) for the prediction of post-transplantation diabetes mellitus (PTDM) and impaired glucose tolerance (IGT) on day 90 after kidney transplantation - a prospective proof of concept study","volume":"S1600\u20136135","author":"Eleftheriadis","year":"2024","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1016\/j.diabres.2025.112076_b0135","doi-asserted-by":"crossref","first-page":"540","DOI":"10.2337\/dc10-1054","article-title":"Hemoglobin A1c and mean glucose in patients with type 1 diabetes: analysis of data from the Juvenile Diabetes Research Foundation continuous glucose monitoring randomized trial","volume":"34","author":"Wilson","year":"2011","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.diabres.2025.112076_b0140","article-title":"Estimation of HbA1c levels in transfusion-dependent thalassemia patients in comparison with normal healthy individuals","volume":"16","author":"Bhatti","year":"2024","journal-title":"Cureus"},{"issue":"7","key":"10.1016\/j.diabres.2025.112076_b0145","first-page":"508","article-title":"Glucose homeostasis markers in beta-thalassemia","volume":"40","author":"Gomber","year":"2018","journal-title":"J PediatrHematolOncol"},{"key":"10.1016\/j.diabres.2025.112076_b0150","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1177\/19322968241242487","article-title":"Continuous glucose monitoring for prediabetes: what are the best metrics?","volume":"18","author":"Zahalka","year":"2024","journal-title":"J Diabetes Sci Technol"},{"issue":"8","key":"10.1016\/j.diabres.2025.112076_b0155","first-page":"907","article-title":"Exploring the continuous glucose monitoring in pediatric diabetes: current practices, innovative metrics, and future implications","volume":"11","author":"Chobot","year":"2024","journal-title":"Children (Basel)"},{"issue":"3","key":"10.1016\/j.diabres.2025.112076_b0160","doi-asserted-by":"crossref","first-page":"400","DOI":"10.2337\/dc18-1444","article-title":"Validation of time in range as an outcome measure for diabetes clinical trials","volume":"42","author":"Beck","year":"2019","journal-title":"Diabetes Care"},{"issue":"10","key":"10.1016\/j.diabres.2025.112076_b0165","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1007\/s00592-023-02097-w","article-title":"Glucose variability: a new risk factor for cardiovascular disease","volume":"60","author":"Belli","year":"2023","journal-title":"Acta Diabetol"},{"issue":"3","key":"10.1016\/j.diabres.2025.112076_b0170","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1089\/dia.2023.0373","article-title":"Aiming for the Best glycemic control beyond time in range: time in tight range as a new continuous glucose monitoring metric in children and adolescents with type 1 diabetes using different treatment modalities","volume":"26","author":"Passanisi","year":"2024","journal-title":"Diabetes Technol Ther"}],"updated-by":[{"DOI":"10.1016\/j.diabres.2025.112101","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000}}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822725000907?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822725000907?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T06:22:48Z","timestamp":1763706168000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822725000907"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":34,"alternative-id":["S0168822725000907"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2025.112076","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterisation of transfusion-dependent prediabetes using continuous glucose monitoring: The Haemoglycare study","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2025.112076","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"112076"}}